🔗 Share this article

A shadow market for unapproved weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the platform has taken down violative content and banned related hashtags and search suggestions. The company said it was dedicated to keeping the platform secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, glowing reviews and step-by-step guides for mixing or injecting at residence.

After minutes of entering one group, a seller posted contact information, where most transactions occur. The vendor sent an instruction manual and promised delivery within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Details and Pricing

Within these groups, posts show dark colored parcels with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Measures

A representative for the messaging service stated it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they can’t verify. Even if the research behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has already seen individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly serious health risks”.